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Identification of the major chemical 
constituents and their metabolites in rat 
plasma and various organs after oral 
administration of effective EXD fraction by 
liquid chromatography-mass spectrometry
Yong Mei Hua, Yi Tao Wangb, Cho-Wing Szea, Qing Liua, Li Dan Zhonga and 
Yao Tonga*
ABSTRACT: A simple and specific LC-DAD-ESI-MS/MS method has been developed and applied for the primary investigation 
of the chemical constituents absorbed or metabolized in vivo, after the rat oral administration of Erxian Decoction (EXD), a 
Chinese medicine prescription for menopausal syndromes. Through the online ESI-MSn analysis, a total of 35 compounds have 
been identified or tentatively characterized from the seven tested samples, and 13 of them were unambiguously identified 
through a direct comparison of the retention time, UV spectra and MSn fragmentation patterns with the authentic ones. The 
results showed that 21 compounds were detected from rat plasma, 20 compounds were detected from rat kidneys and adrenal 
glands, 19 compounds were detected from rat ovaries, 12 compounds were found in rat intestines, nine compounds were 
identified from rat livers and nine compounds were detected from rat brains at certain time points after oral administration 
of the effective EXD fraction. Copyright © 2009 John Wiley & Sons, Ltd.
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Introduction
Traditional Chinese medicine prescriptions (TCMP) have been 
practiced in China for more than 2000 years with few side-effects. 
However, different from Western medicines, TCM prescriptions 
are usually made up of several Chinese herbs, which usually 
contain hundreds of chemical constituents, and this make it hard 
to explain which constituents are responsible for its therapeutic 
properties. The multiplicity of the chemical materials and the 
dimness of their action mechanisms have seriously restricted the 
development of TCMP in the international market. A simple and 
effective analytical method to reveal the possible active constitu-
ents in vivo is in great demand and proved to be significant. In 
recent years, the combined LC-DAD-MSn technique has become 
a much popular approach for the rapid identification of the 
highly polar and non-volatile chemical constituents contained in 
biological matrices at trace levels with the on-line DAD and MS 
detection method (Ma et al., 2008; Ge et al., 2007; Wang et al., 
2005).
Erxian Decoction, composed of Curculigo orchioides Gaertn. 
(Rhizome), Epimedium brevicornum Maxim. (Aerial herb), Morinda 
Officinalis (Root), Anemarrhenae asphodeloides Bge. (Rhizome), 
Phellodendron chinense Schneid. or Phellodendron amurense Rupr. 
(Bark), and Angelica sinensis (Oliv.) Diels (Root), has been practiced 
for the treatment of menopausal syndromes since the 1950s in 
China. Modern pharmacological research has revealed that EXD 
has a comprehensive effect on such multiple targets as hypothala-
mus–pituitary–target gland axis, immune function and free radical 
metabolism (Liu et al., 2005; Nian et al., 2006). Our recent study also 
suggested that EXD treatment would result in increased circula-
tory estrogen level via the activation of aromatase-related pathway 
(Sze et al., 2009). The constituents of EXD are numerous and 
diverse, including alkaloids, phenols, saponins, polysaccharides 
and oligosaccharides, and many of them have been reported to 
possess a wide range of bioactivities (Chen et al., 2007, 2008; Kite 
et al., 2007; Lu et al., 2006; Gong et al., 2003). However, like most of 
the TCM prescriptions, it remains unclear which are the really effec-
tive constituents and their mechanisms of action for menopausal 
syndrome. In this paper, a simple and accurate LC-DAD-MSn 
method was developed for the comprehensive analysis of the 
chemical constituents contained in rat plasma and various organs 
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obtained at certain time points after the oral administration of 
bioactive EXD fraction. A total of 35 chemical constituents, includ-
ing the original compounds and some of their metabolites, have 
been identified or tentatively characterized from the tested 
samples, and 13 of them were unambiguously identified by a 
direct comparison with the standards.
Experimental
Materials and Reagents
Acetonitrile is of HPLC grade from Merck (Darmstadt, Germany). Double-
distilled water was filtered with 0.22 mm nitrocellulose membrane (Mili-Q, 
Bedford, MA, USA). Chemical standards of berberine chloride, palmatine 
chloride, jatrorrhizine chloride, menisperine, magnoflorine, ferulic acid, 
mangiferin, icariin and curculigoside were all purchased from the National 
Institute for Control of Pharmaceutical and Biological Products (NICPBP, 
Beijing China). Epimedin A, B, C and baohuoside I were all prepared and 
elucidated in our laboratory. The purity of each authentic compound was 
determined to be above 96% by HPLC analysis. The dried EXD powders 
were supplied by the NongBen’s Company Ltd (Hong Kong, China). The 
voucher specimens (NB0902) were deposited in the laboratory of the 
School of Chinese Medicine, The University of Hong Kong.
LC-DAD-MS/MS Conditions
A Waters Q-Tof microTM API mass spectrometer (Waters corp., Milford, 
USA) was connected to the HPLC instrument (Waters 2487 DAD) via an 
ESI ion source as interface. Ultra-pure helium (He) was used as the colli-
sion gas and high-purity nitrogen (N2) was used as the nebulizing gas. 
The HPLC conditions for LC-DAD-MS analysis were as follows: an XBridge 
C18 column (2.1 × 150 mm, 5.0 mm, WAT 003110) with an C18 Xbridge 
guard column (4.0 × 2.0 mm, 5.0 mm, Waters) was used at 35°C. A linear 
gradient elution of solvent A (ultra-pure water contains 0.1% formic acid, 
2 mM ammonium acetate) and solvent B (acetonitrile) was applied with 
the following program: 0–20 min, 10–65% B; 20–45 min, 65–80% B; 
45–55 min, 80–65% B. The re-equilibration time was 10 min to the next 
run. The flow rate was 0.25 mL/min, and the injection volume was 10 mL. 
The mass spectrometer conditions were first optimized using flow injec-
tion analysis of the standards without HPLC column. The ESI-MS spectra 
were acquired in both positive and negative modes. The ESI parameters 
were set as follows: capillary voltage, 3.5 kV; sheath gas (N2), 50 arbitrary 
units; nebulizer auxiliary gas (N2), 5 units; extractor, -6 V for (-) ESI and 
6 V for (+) ESI; tube cone voltage, -45 V for (-) ESI and 45 V for (+) ESI. The 
capillary temperature was 350°C and the source block temperature was 
set at 125°C, the cone gas flow rate was 50 L/h, and the mass analyzer 
scanned from 100 to 1000 u. The MS-MS spectra were recorded in auto-
MSn mode, and the fragmentation amplitude was set at 2.0 V.
EXD Sample Preparation
EXD powders (200 g) was dissolved in 100 mL of water, and subject to D101 
macroporous resin, flashed with a gradient ethanol–water (0 : 1–90 : 10) to 
get several sub-fractions. The 20–80% ethanol eluents (D101-EXD) were 
combined and concentrated for final rat administration. The prepared 
D101-EXD fraction was subjected to HPLC analysis and was proved to 
contain all of the chemical constituents contained in EXD. At the same time, 
our pharmacological experiment also showed that the D101-EXD fractions 
have obvious estrogen-like bioactivities in vitro. Stock solutions of 13 refer-
ence compounds were prepared in 75% methanol at 100 mg/mL, respec-
tively, for a direct comparison with the tested EXD sample.
Animals
Eighteen female Sprague–Dawley rats, weighing 220–250 g, were sup-
plied by the Laboratory Animal Unit, The University of Hong Kong. The 
rats were divided into three groups (group A, drug group for blood with-
drawn, n = 6; group B, drug group for tissues obtained, n = 6; group C, 
control group for blank plasma and tissues, n = 6) and kept in an air-
conditioned animal quarters at a temperature of about 24°C and a rela-
tive humidity of 50–65%, with free access to food and water until 12 h 
prior to experiments. The experiment was approved by the Committee 
on the use of Live Animals in Teaching and Research of Li Ka Shing Faculty 
of Medicine, the University of HK.
Drug Administration and Sample Preparation
The D101 fraction (20–80% ethanol eluent) of EXD extract was dissolved 
in 0.1% carboxymethyl cellulose sodium (CMC-Na) aqueous solution and 
was administrated to the rats (2.00 g/kg body weight) by oral gavage. 
Blood samples (100 mL) were withdrawn from the jugular vein before 
dosing and subsequently at 0.5, 1, 2, 3, 4, 8, 10 and 12 h following admin-
istration. The blood samples were placed in heparinized Eppendorf tubes 
and immediately centrifuged at 10,000 rpm for 5 min to separate out 
plasma. The supernatants were mixed and immediately frozen at -20°C 
until analysis. The plasma collected before drug administration were 
combined as blank plasma, and the plasma collected from 0.5 to 12 h 
were combined as drug containing plasma (2). The rats from group B 
were sacrificed by cervical dislocation at 4 h after drug administration. 
The blood and organs used as control were all obtained from rats in 
group C. The original EXD extract was diluted and added to the control 
plasma (1).
The organs, including kidney and adrenal gland, liver, intestine, ovary 
and brain were taken out, weighed and washed with ice-cold normal 
saline. Each organ was put into a clean tube, labeled and stored at -80°C 
until further processing. The rat organs were homogenized with 0.1 mol/L 
PBS buffer (pH 7.4) in the ratio 1 g:5 mL and centrifuged at 10,000rpm for 
20 min. The supernatant were extracted with ethyl acetate for three 
times, then combined and concentrated. The residue was dissolved in 
methanol and centrifuged at 10,000 rpm for 5 min prior to LC/MS/MS 
analysis.
Results and Discussion
The representative LC-DAD-MS chromatograms of blood plasma 
and organs were shown in Figs 1–5. Based on the direct compari-
son with chromatograms of those blank samples and EXD origi-
nal extract (directly added to the rat plasma), a total of 35 
compounds were identified from all the tested samples, and their 
structures are shown in Fig. 6. Among them, 13 compounds were 
unambiguously identified as berberine, palmatine, jatrorrhizine, 
menisperine, magnoflorine, ferulic acid, mangiferin, icariin, cur-
culigoside, Epimedin A, B, C and baohuoside I by a direct com-
parison of the retention time, UV spectra and ESI-MSn 
fragmentation behavior with the reference compounds. The 
comparative ESI-MSn spectra of the representative compounds 
were shown in Fig. 7.
Identification of the Chemical Constituents in Rat Plasma
There were 21 compounds, including seven alkaloids, 10 phenols 
and four saponins, detected in the rat plasma (2) collected from 
0.5 to 12 h after the oral administration of active EXD fraction. 
Compared with the original EXD extract directly added to rat 
plasma (1), four phenolic acompounds and three alkaloids failed 
to be detected from the drug-containing rat plasma (2). It showed 
that most of alkaloids, phenols and saponins contained in EXD 
could be obviously detected in their original forms from the rat 
plasma (2) collected during 12 h after drug administration. 
Among them, five alkaloids were unambiguously identified as 2
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Figure 1. Representative chromatograms of blank plasma. HPLC-DAD chromatogram of blank plasma at 280 nm (A), the negative ESI-MS mode 
chromatogram (B) and the positive ESI-MS chromatogram (C) obtained at 4 h after EXD administration. Representative chromatograms of EXD in rat 
plasma. HPLC-DAD chromatogram of a blank plasma: (1) sample spiked with original EXD at 280 nm (A); rat plasma sample (2) from 0.5 to 12 h after 
oral administration of EXD. (B) The HPLC-DAD chromatogram at 280 nm; (C) the negative ESI-MS mode chromatogram; and (D) the positive ESI-MS 
chromatogram.
3
H1
Co
lo
r O
nl
in
e,
 B
&
W
 in
 P
rin
t
6
3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
Y. M. Hu et al.
www.interscience.wiley.com/journal/bmc Copyright © 2009 John Wiley & Sons, Ltd. Biomed. Chromatogr. 2010; 24: 000–000
Blank Kidney
Time
5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00
-10
90
5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00
-10
90
5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00
0.0
1.0e-1
3: Diode Array 
Range: 1.606e-15.77
7.14
2: Scan ES- 
TIC
5.70e6
22.86
22.81
10.61
5.39 9.92
15.24
11.24 22.67
24.27
27.09
29.58 35.37
33.46
41.72
1: Scan ES+ 
TIC
1.83e7
28.42
27.1322.80
5.84 12.8311.04
7.16 17.20
22.85
30.51 36.89
(A)
(B)
(C)
R
el
at
iv
e 
ab
un
da
nc
e
Time (min)
A
U
Time
5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00
5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00
5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00
Range: 1.521e-16.92
11.20
5.797.12
16.32
12.90
20.12
18.25
21.6423.40
2: Scan ES-
TIC
3.73e6
16.96
15.22
7.13
5.20
0.07 2.02 11.22
14.82
23.4521.66
20.39 27.0925.52
28.76
36.8334.73
30.71 37.81
1: Scan ES+
TIC
3.06e7
20.17
18.28
5.807.16 12.9010.15 16.9215.63
21.06
28.47
27.15
26.44
23.46 30.49 36.72
Kidney
1
10
3
17
2
13
4
5
5
6
9
11
8
8
18
14
7
16
12
171 4
15
14
(A)
(B)
(C)
R
el
at
iv
e 
ab
un
da
nc
e
Time (min)
1.0e-5
0.0
-10
90
90
-10
A
U 26.33
3: Diode Array
Figure 2. Representative chromatograms of blank rat kidney. HPLC-DAD chromatogram of rat kidney at 280 nm (A), the negative ESI-MS mode 
chromatogram (B), and the positive ESI-MS chromatogram (C) obtained at 4 h after EXD administration. Representative chromatograms of EXD 
obsorbed in rat kidney. HPLC-DAD chromatogram of rat kidney at 280 nm (A), the negative ESI-MS mode chromatogram (B), and the positive ESI-MS 
chromatogram (C) obtained at 4 h after EXD administration.
magnoflorine, menisperine, jatrorrhizine, palmatine and berber-
ine by a direct comparison with those standard compounds. The 
molecular structures of the alkaloids were deduced from the 
positive molecular ion peak at m/z [M]+ as well as the corre-
sponding sub-fragments in their MSn spectra (Table 1) (Ma et al., 
2008; Hua et al., 2007; Lu et al., 2006; Zhang et al., 2006). The ion 
fragments at m/z [M - CH3.]+, [M - 2CH3.]+ and [M - CH3O. - CO ]+, 
characteristic of the prototype-berberine alkaloids (21, 25, 26), 
could easily be observed in their ESI-MS spectra, while the ion 
fragments at m/z [M - CH3O.]+, [M - C2H7N.]+ and [M - CH3. - 
C2H7N. - CH3O. - CO - C2H4 - H2O]+ were typical for the aporphine 
alkaloids (6, 13) in the present study. Another nine phenols were 
all unambiguously identified by a direct comparison with the 
reference compounds. The anhydroicaritin flavonoids with a 
prenyl group, which are characteristic for HE species, also showed 
some ESI-MS fragmentation properties under the currently 
applied ESI-MS conditions. In the negative ESI-MS mode, the 
typical ion peak at m/z [M + HCOO-]- could always be observed 
due to the conjugation of the molecular with the added formic 
acid in the mobile phase (Zhao et al., 2008). It also indicated that 
the sugar unite substituted at C-7-O position lost easily, and the 
ion peaks at m/z [M - 7-O-sugar]- for these flavonoids always 4
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Figure 3. Representative 
chromatograms of EXD in rat 
kidney. HPLC-DAD 
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280 nm (a), the negative 
ESI-MS mode chromatogram 
(b), and the positive ESI-MS 
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4 h after EXD administration.
Figure 4. Representative 
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(B), and the positive ESI-MS 
chromatogram (C) obtained at 
4 h after EXD administration.
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Figure 6. The identified compounds from rat plasma and various organs after oral administration of EXD.
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Figure 7. The ESI-MS spectrum of 12 representative compounds.
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Figure 7. Continued
appeared as the base peaks in their ESI-MS1 spectra, while the 
flavonoid (33) with a 3-O-sugar unit showed its base peak at m/z 
[M - H]- in the negative ESI-MS spectrum (Fig. 7). Four saponins 
mainly contained in Rhizoma Anemarrhenae (RA) were also 
detected from rat plasma in the negative or positive electrospray 
mass chromatogram. The quasimolecular ion peak at m/z [M - 
H]- or [M + H]+ usually appeared as the base peak in the first 
moderate ESI-MS spectra, while other fragmentation ions at m/z 
[M ± H - Glc]-, [M ± H - Gal]-, [M ± H - H2O]- and [M ± H - sugar 
units - H2O]- were always observed and served as the important 
additional information for the structure elucidation of these 
saponins (Ma et al., 2008; Hong et al., 1999; Ma et al., 1996; Kang 
et al., 2006). It was found that the saponins 10 and 11 without 
any hydroxyl group in their aglycons could be easily detected in 
the positive ESI-MS chromatogram, while saponins 8 and 9 that 
have hydroxyl groups in their molecular aglycons were detected 
in the negative ESI-MS chromatogram in the present study.
Identification of the Chemical Constituents in Rat Kidney 
and Adrenal Gland
A total of 20 compounds, including six alkaloids, 13 phenols 
(most of them are flavonoids) and one saponin were detected in 
the rat kidneys and adrenal glands obtained at 4 h after drug oral 
administration. It suggested that most of the phenols could be 
absorbed by rat kidney or adrenal gland both in original or their 
metabolite forms in about 4 h after the EXD oral administration, 
while only several main alkaloids were detected in small amounts 
in rat kidney and adrenal gland. It is to be noted that four flavo-
noids (28–30, 33) were detected in rat kidney and adrenal gland 
in higher amounts than those contained in rat plasma and origi-
nal EXD extract. Instead, other four flavonoids (15–18), which 
had higher amounts in the original EXD extract and rat plasma, 
decreased significantly or disappeared completely in rat kidney 
and adrenal gland. It is obvious that the flavonoids 28–30 and 
33 were transferred from the flavonoids 15–18, respectively, in 
vivo by losing their glycosyl groups at 3-O position. The results 
indicated that the flavonoids with more sugar units could easily 
be degraded or metabolized to their sub-degradation product in 
vivo. On the other hand, they possibly pointed out that the 
kidney or its adrenal gland was one of the most sensitive target 
organs of the phenolic compounds contained in EXD. In addition, 
they suggested that the original flavonoids and alkaloids metab-
olize rapidly and could not accumulate in vivo.
Most of the original compounds found in rat kidney and 
adrenal gland were the same as that found in rat plasma and 
showed similar fragmentation patterns in their ESI-MSn spectra. 
The metabolized flavonoids with their C-3-O-sugar units being 
hydrolyzed showed the base ion peak mainly at m/z [M - H]- in 
the ESI-MS spectrum in the present study.
Identification of the Chemical Constituents in Rat Ovary
Eighteen compounds, including four alkaloids, 13 phenols and 
one saponin were detected in the rat ovary obtained at 4 h after 
the oral administration of EXD. It seemed that only minor 
amounts of the alkaloids were absorbed by the ovary during this 
time. Similar to the rat kidney and adrenal gland, the rat ovary 8
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Table 1. Chemical constituents and their metabolites idendified from rats plasma and organs at certain time points
No. Rt (min) Identification Detected resource M+ [M - H]- HPLC-ESI-MSn (m/z) (%base peak) Rsa
1 2 3 4 5 6 7 (m/z) (m/z) MS2: Sub-fragments from first base peaks
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5
6
7
8
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11.24
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11.85
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13.25
13.48
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13.88
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14.49
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15.46
15.63
16.10
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16.32
16.91
17.47
Neomangiferin
Mangiferina
Lotusine
(-)-Oblongine
3-O-feruoylquinic acid
Magnoflorinea
Phellodendrine
Timosaponin N
Timosaponin D
Xilingsaponin B
Timosaponin B-II
Ferulic acida
Menisperinea
Curculigosidea
Epimedin Aa
Epimedin Ba
Epimedin Ca
Icariina
A#
+
+
+
+
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+
+
+
+
+
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+
+
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314
314
-
342
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-
-
903b
921b
-
356
-
-
808b
823b
677b
-
583
421
—
—
367
—
—
935
917
—
919
193
—
465
837
807
821
675
819
MS2: 583, 421, 331, 220, 293, 193
421, 403, 331, 301(50), 293, 220
MS2: 331, 301[M - 120]-, 293, 193, 147
314, 298[M - CH4]+ (55), 270, 269
314, 298, 296, 283(5), 268
MS2: 367: 193, 191, 173, 167, 112
MS2: 342: 297, 265, 209, 192, 162(15)
MS2:342: 312, 297, 264, 192, 164
935, 917, 755, 493;MS2: 773, 742, 611, 455, 449
MS2: 755, 773, 611, 314
903, 857, 740, 434, 417, 399, 356
MS2:740, 561, 417, 399, 328, 304, 286
919, 901, 864, 757, 722, 464, 353
MS2: 757, 595, 577, 433, 415, 389
193, 179, 151, 149
MS2: 356: 311, 296, 279, 225, 192, 190
446, 340, 303; MS2: 301, 285, 281, 251
837, 675, 352; MS2:367, 352, 311, 283
807, 645, 343;MS2:367, 352, 323, 311
821, 659, 513;MS2:367, 352, 323, 279
721, 675, 513, 409, 261;
MS2: 367, 351, 323, 311, 280, 268
819, 657, 513, 367; MS2: 513, 366, 346, 323
6
6
5
5
5
5
5
6
6
6
6
4
5
1
2
2
2
2
2
20
21
22
23
24
25
26
27
28
29
30
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32
33
34
35
18.01
18.07
18.50
18.65
18.78
19.98
20.82
20.86
20.92
21.32
21.64
21.67
21.89
23.47
23.89
24.74
Icariside I
Jatrorrhizinea
Methoxyl-icariin
Iso-sagittatoside A
Metablite of alkaloid
Palmatinea
Berberinea
Anemarrhenasaponin I
Sagittatoside A
Sagittatoside B
2″-O-rhamnosyl -icarisideII
Isomer of berberine
Icariin-7-O-rhamnoside
Baohuoside Ia (Icariside II)
B#
Rubiadin-1-methyl ether
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+
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+
+
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-
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-
+
-
+
531b
338
-
370
352
336
-
677b
-
661b
336
-
515b
529
—
705
675
—
—
—
757
675
645
659
—
659
513
657
267
531, 513, 369; MS2: 369, 313
338, 323, 294, 217;MS2:323, 294, 148
705, 614, 529, 513,
675, 578, 367, 352, 311, 297
370, 338, 323, 279, 218, 136
352, 337, 308, 293;
MS2: 337, 322(60), 308, 291, 190
336, 321, 292, 242;
MS2: 321, 292, 275, 242, 186
757, 738, 718, 698, 389, 342, 197
MS2:499, 433, 415, 342, 146
MS2: 675, 578, 366, 351(20), 311, 297
MS2: 645, 495, 366, 351(45), 323, 268
659, 513, 367, 366, 352, 351, 323
MS2:659, 513, 366, 351, 323, 295, 280
352, 336, 321, 292, 242
659, 513, 470, 367; MS2:366, 351, 323
513, 383, 367, 323, 264;
MS2: 367, 352,323, 312, 295
679 [M - H+Na], 657, 513, 497, 367(45)
267, 253, 251, 237, 209;MS2: 209, 179 (30)
2
5
2
2
5
5
5
6
6
2
2
2
5
2
2
2
3
Rs, The number of crude drug item means which crude drug in the ingredient belong to: (1) Rhizome Curliginis; (2) Herba Epimedii; (3) Radix 
Morindae Officinalis; (4) Radix Anemarrhenae; (5) Cortex Phellodendri; (6) Radix Angelicae sinensis.
Bold characters: the base peaks (100%) in ESI-MS spectra.
A#: Icariin-3-rha(1–4)furan acid; B#: Baohuoside I-rha(1–2) furan acid. Italic type means the metabolites of the original compounds;
a The compounds were identified unambiguously by direct comparison with the authentic ones; b [M + H]+.
1, Original EXD in plasma (27); 2, plasma (21); 3, kidney (20); 4, ovary (19); 5, small intestine (12); 6, liver (9); 7, brain (9).
also proved to be the one of the most sensitive target organs of 
the anti-oxidant flavonoids contained in EXD. It showed that 
most of the detected flavonoids were the sub-degradation prod-
ucts of the original ones with the C-7-O-glycosyl being hydro-
lyzed. This phenomenon suggested that most of the flavonoid 
could pass through the placenta barrier easier than alkaloids. The 
18 compounds showed a similar ESI-MSn fragmentation behavior 
to those detected in rat kidney and adrenal glands.
Identification of the Chemical Constituents in Rat Small 
Intestine
A total of 12 compounds, including five alkaloids, six flavonoids 
and one saponin were detected in the rat intestine obtained at 
4 h after the oral administration of EXD. It could be seen that 
fewer compounds originally contained in EXD were detected 
from the rat intestine at 4 h after drug administration. This indi-
cated that most of the chemical constituents contained in EXD 
possibly have been eliminated from rat intestine during this time. 
The ESI-MSn fragmentation patterns of these compounds were 
identical to those detected in rat plasma and kidneys.
Identification of the Chemical Constituents in Rat Liver
Only nine compounds, including three alkaloids, six flavonoids 
were detected in the rat liver obtained in 4 h after the oral admin-
istration of EXD. Most of the flavonoids were found to be the sub-
metabolites with some glucosyl units at C-3-O being hydrolyzed 9
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through the metabolism. The liver is one of the heaviest organs in 
rat, while in the present study most of the original compounds 
failed to be detected in liver. This possibly could be explained by 
the rapid metabolism or elimination velocity of these chemicals in 
rat liver. The fragmentation patterns of these compounds were 
similar to those detected in rat plasma and kidneys.
Identification of the Chemical Constituents in Rat Brain
Nine typical compounds, including the maniferin, ferulic acid, 
icarrin, baohuoside I, sagittatoside A, rubiadin-1-methyl ether, 
berberine, palmatine and jatrorrhizine were all obviously 
detected in rat brains obtained at 4 h after the oral administra-
tion of EXD. It is well known that any drugs or chemical constitu-
ents which can enter the brain must overcome the blood–brain 
barrier (BBB) first, and only those compounds that have a smaller 
molecular size and lower polarity can pass through the BBB and 
be absorbed into the brain easily. It is suggested that some of the 
original compounds contained in EXD can get through the BBB 
and act on the brain directly. The baohuoside I, in relatively 
higher amounts, should be the final metabolite of the original 
flavonol glycosides (15–19; 28–30) by losing some of their sugar 
units in their molecular during the metabolism process. The 
ESI-MSn spectra of these compounds were comparable to those 
observed in rat plasma and rat ovary.
Discussion and Conclusion
Through the combined LC-DAD-MSn techniques, a total of 35 
compounds were simultaneously detected and identified from 
rat plasma and various organs in their original or metabolitic 
forms after oral administration of the bio-active EXD fraction. 
The results indicated that most of the phenols (mainly flavo-
noids), alkaloids and saponins could easily be absorbed into rat 
blood through oral administration of EXD. The flavone glyco-
sides could be metabolized or eliminated from the body quickly; 
however their sub-degradation product will stay in kidney, 
adrenal gland and ovary for a longer time (at least 4 h). It is also 
suggested that the kidney, adrenal gland and ovary are the 
most sensitive target organs for those antioxidative flavonoids 
and their sub-metabolites. More interestingly, several small 
molecular compounds could pass through the BBB and be 
absorbed into rat brain directly. On the other hand, the iso-
quinoline alkaloids as the main constituents of Cortex 
Phellodendri were easily detected from all of the tested rat 
organs and plasma, and some of their metabolites were also 
found in rat liver and kidney after drug administration. Bioactive 
studies by our research group also found that these detected 
flavonoids, alkaloids and saponins are the most effective con-
stituents contained in EXD. Some metabolized flavonoids, e.g. 
the baohuoside I, were also proved to have obvious estrogen-
like bioactivities in vitro. A further pharmacological investigation 
of the sub-metabolites based on our pharmacokinetic study will 
be carried out in the future.
It is well known that there are two major routes of drug admin-
istration—enteral and parenteral (Fig. 8). Giving a drug orally is 
the most common route of enteral administration, especially for 
the TCM formula when used in the clinic. Only the constituents 
successfully absorbed into the blood and kept at a considerable 
concentration level in target organs can perform their therapeu-
tic functions. Our present work through the comprehensive 
analysis of all the chemical constituents and their metabolites 
contained in rat plasma and various organs at certain time 
points, provides the preliminary profile of the absorption, distri-
bution, metabolism and elimination of EXD in vivo (Fig. 9). A 
more comprehensive pharmacokinetic study about the various 
rat organs and plasma obtained at different time points should 
be followed up in future. The results will on the other hand elu-
cidate the real action target and medicinal mechanism of EXD in 
vivo.
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Figure 8. First-pass metabolism can occur with orally administrated drugs.10
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